Related Experiment Video
Updated: Sep 20, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Risk Factors for Acute Cholangitis Caused by Extended-Spectrum Beta-Lactamase and AmpC-Producing Organisms
Takuro Nishiwaki1,2, Shigenobu Yoshimura1, Naoto Hosokawa3
1Department of Gastroenterology, Kameda Medical Center, Kamogawa, Japan.
Introduction:
Prompt antibiotic administration is essential in the management of acute cholangitis (AC). In selecting initial antibiotics, it is important to consider both the severity of the condition and the antimicrobial activity spectrum, particularly against major resistant bacteria. Extended-spectrum β-lactamases and AmpC productions are key factors in pathogen resistance; however, knowledge of patient characteristics in cholangitis management remains limited. We aimed to analyze risk factors for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and for chromosomally mediated AmpC-producing Enterobacteriaceae (CAE).
Methods:
This study retrospectively analyzed patients with AC who underwent endoscopic retrograde cholangiopancreatography (ERCP) at a tertiary center in Japan between April 1, 2018, and April 30, 2024. This analysis focused on evaluating the first episode of AC during hospitalization.
Results:
A total of 721 patients with cholangitis underwent ERCP. ESBL-E was detected as the causative pathogen in 22 cases, whereas CAE was identified in 113 cases. Patients with CAE experienced a significantly higher recurrence rate within 60 days (15.9% vs. 4.3%, p < 0.001) and required more frequent escalation to broad-spectrum antibiotics (19.5% vs. 8.7%, p = 0.001). No significant differences in clinical outcomes were observed between patients with and without ESBL-E. Multivariate analysis identified independent risk factors for AC caused by ESBL-E: previous antibiotic use within 90 days, dialysis, and residence in nursing homes. For CAE, independent risk factors included antibiotic use within 90 days and a history of endoscopic sphincterotomy (EST).
Conclusion:
In AC, recent antibiotic use, dialysis, and institutionalization are associated with ESBL-E, whereas recent antibiotic use and a history of EST are linked to CAE.
Insights
Risk factors for resistant bacteria in acute cholangitis (AC) include prior antibiotic use, dialysis, and nursing home residence for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). Chromosomally mediated AmpC-producing Enterobacteriaceae (CAE) risk factors include prior antibiotic use and endoscopic sphincterotomy history.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Microbiology
Background:
- Prompt antibiotic administration is critical for acute cholangitis (AC) management.
- Selecting antibiotics requires considering severity and resistance patterns, especially for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and chromosomally mediated AmpC-producing Enterobacteriaceae (CAE).
- Patient characteristics influencing resistance in AC are not well understood.
Purpose of the Study:
- To identify risk factors associated with ESBL-E and CAE in patients with AC.
Main Methods:
- Retrospective analysis of 721 AC patients undergoing ERCP at a tertiary center in Japan (April 2018 - April 2024).
- Focused on the first AC episode during hospitalization.
- Multivariate analysis was used to determine independent risk factors.
Main Results:
- CAE (113 cases) showed higher recurrence rates (15.9% vs. 4.3%) and more frequent broad-spectrum antibiotic escalation (19.5% vs. 8.7%) compared to ESBL-E (22 cases).
- No significant clinical outcome differences were observed between ESBL-E and non-ESBL-E groups.
- Independent risk factors for ESBL-E included prior antibiotic use, dialysis, and nursing home residence.
- Independent risk factors for CAE included prior antibiotic use and history of endoscopic sphincterotomy (EST).
Conclusions:
- Recent antibiotic use, dialysis, and institutionalization are linked to ESBL-E in AC.
- Recent antibiotic use and a history of EST are associated with CAE in AC.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pyelonephritis II: Diagnostic Studies and Management
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...